Dare Bioscience Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: DARE
Share price (9/22/26): $0.85
Market cap (9/22/26): $16.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 73 pages Plan of reorganization, merger, acquisition or similar

from 8-K 36 pages Asset Purchase Agreement

from DEFA14A 36 pages Asset Purchase Agreement

from DEFA14A 35 pages Asset Purchase Agreement

from 8-K 35 pages Asset Purchase Agreement

from 8-K 106 pages Stock Purchase Agreement by and Among Cerulean Pharma Inc., Daré Bioscience, Inc. the Stockholders of Daré Bioscience, Inc. and Solely in Such Person’s Capacity as Stockholder Representative, Sabrina Martucci Johnson Dated as of March 19, 2017

from DEFA14A 106 pages Stock Purchase Agreement by and Among Cerulean Pharma Inc., Daré Bioscience, Inc. the Stockholders of Daré Bioscience, Inc. and Solely in Such Person’s Capacity as Stockholder Representative, Sabrina Martucci Johnson Dated as of March 19, 2017